Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1998-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.42.6.1346PMID 9624473PMCID PMC105601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.

  1995cited by this paper
• Marked variation in pyrimethamine disposition in AIDS patients treated for cerebral toxoplasmosis.

  1995cited by this paper
• USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Introduction

  1995cited by this paper
• Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients

  1995cited by this paper
• U.S. Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.

  1995cited by this paper
• Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS

  1992cited by this paper
• Toxoplasmic encephalitis in AIDS.

  1992cited by this paper
• Cotrimoxazole therapy ofToxoplasma gondii encephalitis in AIDS patients

  1992cited by this paper
• Treatment of Toxoplasmic Encephalitis in Patients with AIDS

  1992cited by this paper
• Toxoplasma Encephalitis in Patients with the Acquired Immunodeficiency Syndrome

  1992cited by this paper
• A retrospective study about the use of cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS.

  1990cited by this paper
• Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.

  1990cited by this paper
• Toxoplasmic encephalitis.

  1990cited by this paper
• In vitro effects of folate inhibitors on Toxoplasma gondii

  1989cited by this paper
• Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.

  1989cited by this paper
• Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study.

  1988cited by this paper
• Treatment of toxoplasmic encephalitis with intravenous clindamycin.

  1988cited by this paper
• AIDS commentary. Toxoplasmic encephalitis.

  1988cited by this paper
• Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.

  1988cited by this paper
• Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.

  1987cited by this paper
• Assessment of therapy for toxoplasma encephalitis. The TE Study Group.

  1987cited by this paper
• Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.

  1987cited by this paper
• Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.

  1985cited by this paper
• Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.

  1985cited by this paper
• Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges

  1984cited by this paper
• The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.

  1979cited by this paper
• Cerebrospinal fluid concentrations of trimethoprim during oral and parenteral treatment.

  1979cited by this paper

• Spinal Cord Toxoplasmosis: Mapping the Journey of a Rare Entity Through a Case Report and Review of the Literature

  2026cites this paper
• Acetazolamide as a Novel Therapeutic Agent against Acute Experimental Toxoplasmosis: Insights into Carbonic Anhydrase Inhibition.

  2026cites this paper
• Preventing laboratory-acquired Toxoplasma gondii infection: literature review and case-based post-exposure prophylaxis proposal

  2026cites this paper
• Dissecting mammalian cortical circuit development at single-cell resolution using inducible barcoded rabies virus

  2025cites this paper
• Inhibition of Src signaling induces autophagic killing of Toxoplasma gondii via PTEN-mediated deactivation of Akt

  2025cites this paper
• Evaluation of anti-Toxoplasma effects of lipid nanoparticles carrying tea tree oil on Toxoplasma gondii tachyzoites in Vero cells

  2025cites this paper
• Clinical courses and outcomes of cerebral toxoplasmosis in HIV-positive patients in Shiraz, Southern Iran: a retrospective study

  2025cites this paper
• CNS infections in patients with hematological or oncological diseases (including cellular therapies) - 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

  2025cites this paper
• Evaluation of anti-Toxoplasma effects of solid lipid nanoparticles carrying Cinnamon zeylanicum and Moringa oleifera oil extracts

  2024cites this paper
• Cloning, expression, and purification of an α-carbonic anhydrase from Toxoplasma gondii to unveil its kinetic parameters and anion inhibition profile.

  2024cites this paper
• Anti‐Toxoplasma gondii activity of rose hip oil–solid lipid nanoparticles

  2024cites this paper
• Exploring the Inhibition of Toxoplasma gondii α-Carbonic Anhydrase by Sulfonamides: Insights into Potential Drug Targeting

  2024cites this paper
• Combination of trimethoprim-sulfamethoxazole and clindamycin in the treatment of relapsing toxoplasmic encephalitis.

  2024cites this paper
• The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa

  2023cites this paper
• A case report of a successful alternative regiment therapy for toxoplasma encephalitis in AIDS patients

  2023cites this paper
• Metagenomic Next-generation Sequencing May be a Tool for Timely Diagnosis of Seronegative and Primary Toxoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review

  2023cites this paper
• Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.

  2023cites this paper
• Revisiting the Evidence Base for Modern Day Practice of the Treatment of Toxoplasmic Encephalitis: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial

  2022cites this paper
• Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.

  2022cites this paper
• microRNA-155 Expression and Butyrylcholinesterase Activity in the Liver Tissue of Mice Infected with Toxoplasma gondii (Avirulent and Virulent Strains)

  2021cites this paper
• Infections of the Spine and Spinal Cord

  2021cites this paper
• Central nervous system infections after solid organ transplantation

  2021cites this paper
• Case Report: Immune Dysregulation Due to Toxoplasma gondii Reactivation After Allogeneic Hematopoietic Cell Transplant

  2021influential citation
• Treatment of toxoplasmic encephalitis with the combination of clindamycin plus azithromycin in an HIV‐infected patient: A case report

  2021cites this paper
• An immunocompetent young man with diffuse pulmonary infiltrates

  2020cites this paper
• Human Immunodeficiency Virus Infection

  2020cites this paper
• Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

  2020cites this paper
• Toxoplasma gondii in Solid Organ and Stem Cell Transplant: Prevention and Treatment

  2020cites this paper
• Toxoplasmosis

  2020cites this paper
• Treatment of toxoplasmosis: Current options and future perspectives

  2019influential citation
• Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis.

  2019cites this paper
• Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.

  2019cites this paper
• Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial

  2019cites this paper
• HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease

  2019cites this paper
• Concomitant Central Nervous System Toxoplasmosis and Seronegative Disseminated Coccidioidomycosis in a Newly Diagnosed Acquired Immune Deficiency Syndrome Patient

  2019cites this paper
• Management of Advanced Human Immunodeficiency Virus Disease.

  2019cites this paper
• Parasitic Diseases Within the Spinal Cord and Nerve Roots

  2019cites this paper
• Infections in Hematopoietic Stem Cell Transplant Recipients

  2018cites this paper
• Successful Treatment of Cerebral Toxoplasmosis Using Pyrimethamine Oral Solution Compounded From Inexpensive Bulk Powder

  2018cites this paper
• Management of toxoplasmosis in transplant recipients: an update

  2018cites this paper
• Anti-infective treatment of brain abscess

  2018cites this paper
• Management of Infections in the Immunocompromised Host

  2018cites this paper
• Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice

  2018cites this paper
• Recurring and emerging questions related to management of HIV-related opportunistic infections.

  2018cites this paper
• Repurposing of commercially available anti-coccidials identifies diclazuril and decoquinate as potential therapeutic candidates against Besnoitia besnoiti infection.

  2018cites this paper
• HEMIPLEGIA IN A CASE OF HIV

  2018cites this paper
• Prevalence of Toxoplasma gondii infection in HIV-infected patients and food animals and direct genotyping of T. gondii isolates, Southern Ghana

  2017cites this paper
• Systematic review and meta-analysis of secondary prophylaxis for prevention of HIV-related toxoplasmic encephalitis relapse using trimethoprim-sulfamethoxazole

  2017cites this paper
• Stability of a pyrimethamine suspension compounded from bulk powder

  2017cites this paper
• Addressing Antiretroviral Therapy‐Associated Drug‐Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low‐Income and Resource‐Limited Settings

  2017cites this paper
• Drugs in development for toxoplasmosis: advances, challenges, and current status

  2017cites this paper
• Bacterial infection imaging with [18F]fluoropropyl-trimethoprim

  2017cites this paper
• Successful Treatment of Pulmonary and Cerebral Toxoplasmosis Associated with Pneumocystis Pneumonia in an HIV Patient

  2017cites this paper
• Toxoplasmic Encephalitis

  2017cites this paper
• Infections in Immunocompromised Patients

  2017cites this paper
• A systematic review and meta‐analysis of the relative efficacy and safety of treatment regimens for HIV‐associated cerebral toxoplasmosis: is trimethoprim‐sulfamethoxazole a real option?

  2017cites this paper
• Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis

  2017cites this paper
• Addressing Antiretroviral TherapyAssociated DrugDrug Interactions in Patients Requiring Treatment for Opportunistic Infections in LowIncome and ResourceLimited Settings

  2017cites this paper
• Toxoplasmosis After Solid Organ Transplantation

  2016cites this paper
• Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.

  2016cites this paper
• Development of DNA and recombinant vaccines against toxoplasma gondii infection / Ching Xiao Teng

  2016cites this paper
• CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

  2016cites this paper
• HIV/AIDS RESEARCH AND TREATMENT

  2015cites this paper
• Cerebral Toxoplasmosis in a Treatment Naive HIV Patient with High CD4 Count Responding to Treatment with a Regime of Cotrimoxazole and Pyrimethamine: Do We Need to Start Prophylaxis for Toxoplasmosis at a Higher CD4 Count?

  2015cites this paper
• Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting

  2015cites this paper
• Toxoplasmosis Gondii Infection and Diabetes Mellitus Type 2 Treated by Using Autologous Peripheral Blood Stem Cells a Unique Case Report of a Caucasian 83 Year Old Lady

  2015cites this paper
• Toxoplasmose cérébrale

  2015cites this paper
• Central Nervous System Infections

  2015cites this paper
• Sulfonamides and Trimethoprim

  2015cites this paper
• 131 – Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection

  2015cites this paper
• Neurologic complications in renal transplantation.

  2014cites this paper
• Targeting protozoan parasite metabolism: glycolytic enzymes in the therapeutic crosshairs.

  2014cites this paper
• Toxoplasmosis of Spinal Cord in Acquired Immunodeficiency Syndrome Patient Presenting as Paraparesis: A Rare Entity

  2014cites this paper
• 10 – Clinical Features and Management of HIV/AIDS

  2014cites this paper
• Toxoplasmose & Toxoplasma gondii

  2014cites this paper
• Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)

  2013cites this paper
• Toxoplasmosis cerebral en pacientes con SIDA en el Hospital Nacional Cayetano Heredia entre 1989 y 1999

  2013cites this paper
• Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/OAG) (AWMF 055/066)

  2013cites this paper
• Toxoplasma gondii Infection in Kyrgyzstan: Seroprevalence, Risk Factor Analysis, and Estimate of Congenital and AIDS-Related Toxoplasmosis

  2013cites this paper
• Antibiotics for human toxoplasmosis: a systematic review of randomized trials

  2013cites this paper
• Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediat

  2013cites this paper
• Parasitic Infections in Solid Organ Transplantation

  2013cites this paper
• Toxoplasmosis after Kidney Transplantation

  2013cites this paper
• Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients.

  2013cites this paper
• 27 – Human Immunodeficiency Virus Infection

  2013cites this paper
• Leukemia and related disorders

  2012cites this paper
• Utilisation du modèle CEPAC en appui à la recherche clinique dans le domaine de la prise en charge des adultes infectés par le VIH en Afrique sub-saharienne

  2012cites this paper
• Chapter 31 – AIDS-associated toxoplasmosis

  2012cites this paper
• Diagnóstico y tratamiento de infecciones oportunistas en el paciente adulto con infección por VIH/SIDA

  2011cites this paper
• [Diagnosis and treatment of opportunistic infections in HIV/AIDS adult patients].

  2011cites this paper
• Toxoplasmosis in a patient who was immunocompetent: a case report

  2011cites this paper
• Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites

  2011cites this paper
• 2 Central nervous system opportunistic infections

  2011cites this paper
• Introduction to the Symposium on Antimicrobial Therapy

  2011cites this paper
• Toxoplasmosis

  2011cites this paper
• Infections in Leukemia and Hematopoietic Stem Cell Transplantation

  2011cites this paper
• Cerebral Toxoplasmosis as the Presenting Manifestation of HIV/AIDS

  2011cites this paper
• Analytic Review: Neurological Complications of Transplantation

  2011cites this paper
• Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1–PDL-1 blockade

  2011cites this paper